Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery [NA]
An update on a clinical trial comparing endhole versus pressure-modulated Lipiodol delivery for hepatocellular carcinoma and neuroendocrine …
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use [Phase 1, Phase 2]
An imaging study using [68]Ga-HA-DOTATATE to identify/diagnose tumors with somatostatin receptors is being evaluated for safety and diagnost…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. [NA]
This is a prospective study (EQUITY GI) to improve quality, inclusivity, and trial participation for Black patients with gastrointestinal ca…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study [Phase 1]
Phase 1 study evaluating HBM4003 in combination with toripalimab in patients with advanced neuroendocrine tumors and other solid tumors, inc…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: TARGETed Therapy Drug MONITOring in DIGestive Oncology [NA]
UNICANCER-sponsored clinical trial is recruiting a targeted therapy monitoring study in digestive oncology, including metastatic colorectal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours [Phase 1]
Phase 1 clinical trial evaluating a PARP inhibitor combined with 177Lu-DOTA-Octreotate peptide receptor radionuclide therapy in patients wit…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Clinical Application of the J-PET Scanner Prototype
Clinical trial update announcing recruitment for a prototype J-PET scanner. The study targets imaging in prostate cancer, benign prostatic h…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
A multicenter retrospective study on prognostic and predictive factors in neuroendocrine tumors, sponsored by the Latin American Cooperative…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study
The NEMESIs-study evaluates a methylation-based classifier for neuroendocrine tumors and is reported as completed.
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecolog…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Clinical-pathological Evaluation of Pit-NETs
This clinical trial update describes a study evaluating the clinical and pathological features of pituitary neuroendocrine tumors (Pit-NETs)…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors [Phase 2]
Phase 2 trial update evaluating the optimal interval between cycles of Lutathera (177Lu-DOTATATE) peptide receptor radionuclide therapy in S…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: 68Ga-DOTA-TATE PET/CT Imaging in NETs [Phase 3]
A Phase 3 clinical trial is evaluating 68Ga-DOTA-TATE PET/CT imaging for neuroendocrine tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis
This is a retrospective analysis using 18F-DOPA PET/CT to assess heterogeneity in metastatic neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2023-12-05Clinical Trial Update: 68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating 68Ga-DOTA-MGS5 PET/CT imaging in patients with advanced neuroendocrine tumors has completed.
-
CLINICAL_TRIALS research · 2018-11-29Clinical Trial Update: An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1) [Phase 4]
Phase 4 open-label expanded access study of everolimus in advanced neuroendocrine tumors completed; results posted in 2018.
-
CLINICAL_TRIALS research · 2017-12-13Clinical Trial Update: Psychosocial Screening for Neuroendocrine Tumor Patients
A clinical trial update describing psychosocial screening for patients with neuroendocrine tumors. The current study status is unknown.